Get the Stockscreener App
0.001
232.23%
0.000699
Acura Pharmaceuticals Inc. Stock (ACUR) Forecast
The Acura Pharmaceuticals Inc. (ACUR) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.4986, representing a +49,764% increase from the current price of $0.001. The highest analyst price target is $0.5082, and the lowest is $0.4891.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ACUR Price Target
Average 0.4534
(+45,241% Upside)
Long-term ACUR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Acura Pharmaceuticals Inc. financial reports and earnings history, Acura Pharmaceuticals Inc. (ACUR) stock could reach $1.2909 by 2030, $2.2791 by 2040 and $4.6939 by 2050. See the projected annual prices until 2050 of the Acura Pharmaceuticals Inc. stock below:
- Acura Pharmaceuticals Inc. (ACUR) is expected to reach an average price of $1.7405 in 2035, with a high prediction of $2.0627 and a low estimate of $1.7405. This indicates an $173.95K% rise from the last recorded price of $0.001.
- Acura Pharmaceuticals Inc. (ACUR) stock is projected to chart a bullish course in 2040, with an average price target of $1.8209, representing an $181.99K% surge from its current level. The forecast ranges from a conservative $1.8209 to a sky-high $2.2791.
- Our analysts predict Acura Pharmaceuticals Inc. (ACUR) to jump 401.04K% by 2045, soaring from $2.0609 to an average price of $4.0114, potentially reaching $4.1701. While $2.0609 is the low estimate, the potential upside is significant.
- Acura Pharmaceuticals Inc. (ACUR) stock is expected to climb by 2050, reaching an average of $4.0607, a $405.97K% jump from its current level. However, a wide range of estimates exists, with high and low targets of $4.6939 and $4.0607, respectively, highlighting the market's uncertainty.
Acura Pharmaceuticals Inc. Stock (ACUR) Year by Year Forecast
Acura Pharmaceuticals Inc. Stock (ACUR) Price Forecast for 2025
Acura Pharmaceuticals Inc. Stock (ACUR) is expected to reach an average price of $0.3317 in 2025, with a high prediction of $0.5082 and a low estimate of $0.1552. This indicates an +33,070% rise from the last recorded price of $0.001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| October, 2025 | $0.4927 | $0.4891 | $0.5082 | +49,173% |
| November, 2025 | $0.3659 | $0.3959 | $0.4673 | +36,491% |
| December, 2025 | $0.2636 | $0.2636 | $0.3455 | +26,264% |
Acura Pharmaceuticals Inc. Stock (ACUR) Price Forecast for 2026
The predicted value for Acura Pharmaceuticals Inc. (ACUR) in 2026 is set at an average of $0.478. Estimates vary from a peak of $0.7127 to a trough of $0.2432, indicating an +47,695% surge from the present price of $0.001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $0.545 | $0.2432 | $0.545 | +54,400% |
| February, 2026 | $0.515 | $0.515 | $0.56 | +51,400% |
| March, 2026 | $0.3625 | $0.3625 | $0.4925 | +36,150% |
| April, 2026 | $0.3063 | $0.2725 | $0.34 | +30,525% |
| May, 2026 | $0.6364 | $0.6009 | $0.6009 | +63,536% |
| June, 2026 | $0.5186 | $0.5186 | $0.6118 | +51,764% |
| July, 2026 | $0.3755 | $0.3755 | $0.4491 | +37,445% |
| August, 2026 | $0.6534 | $0.3018 | $0.6534 | +65,241% |
| September, 2026 | $0.642 | $0.642 | $0.6636 | +64,105% |
| October, 2026 | $0.4907 | $0.5207 | $0.6105 | +48,968% |
| November, 2026 | $0.3577 | $0.3577 | $0.4641 | +35,673% |
| December, 2026 | $0.7127 | $0.3311 | $0.7127 | +71,173% |
Acura Pharmaceuticals Inc. Stock (ACUR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Acura Pharmaceuticals Inc. (ACUR) is $0.6228, with a high forecast of $0.8852 and a low forecast of $0.3605. This indicates an +62,184% increase from the last price of $0.001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.6582 | $0.6582 | $0.7155 | +65,718% |
| February, 2027 | $0.5036 | $0.5036 | $0.6295 | +50,264% |
| March, 2027 | $0.4177 | $0.3605 | $0.475 | +41,673% |
| April, 2027 | $0.798 | $0.7686 | $0.7693 | +79,695% |
| May, 2027 | $0.6495 | $0.6495 | $0.7673 | +64,855% |
| June, 2027 | $0.4818 | $0.4818 | $0.5739 | +48,082% |
| July, 2027 | $0.85 | $0.3898 | $0.7501 | +84,900% |
| August, 2027 | $0.7914 | $0.7914 | $0.8273 | +79,036% |
| September, 2027 | $0.6155 | $0.6455 | $0.7536 | +61,445% |
| October, 2027 | $0.4845 | $0.4845 | $0.5827 | +48,355% |
| November, 2027 | $0.8805 | $0.4191 | $0.8852 | +87,945% |
| December, 2027 | $0.8014 | $0.8014 | $0.8709 | +80,036% |
Acura Pharmaceuticals Inc. Stock (ACUR) Price Forecast for 2028
In 2028, Acura Pharmaceuticals Inc. (ACUR) is projected to reach an average price of $0.7537, with a high projection of $1.0591 and a low estimate of $0.4484. This indicates an +75,275% rise from the last price of $0.001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.5875 | $0.5875 | $0.7666 | +58,650% |
| February, 2028 | $0.5006 | $0.4484 | $0.5527 | +49,957% |
| March, 2028 | $0.9595 | $0.9364 | $0.9432 | +95,855% |
| April, 2028 | $0.8173 | $0.8173 | $0.9227 | +81,627% |
| May, 2028 | $0.5882 | $0.5882 | $0.7805 | +58,718% |
| June, 2028 | $1.03 | $0.4777 | $0.9301 | +102.90K% |
| July, 2028 | $0.9407 | $0.9407 | $1.0011 | +93,968% |
| August, 2028 | $0.7402 | $0.7702 | $0.8968 | +73,923% |
| September, 2028 | $0.5848 | $0.5848 | $0.7014 | +58,377% |
| October, 2028 | $1.0482 | $0.507 | $1.0591 | +104.72K% |
| November, 2028 | $0.9445 | $0.9445 | $1.0264 | +94,355% |
| December, 2028 | $0.7409 | $0.7409 | $0.9036 | +73,991% |
Acura Pharmaceuticals Inc. Stock (ACUR) Price Forecast for 2029
The 2029 price forecast for Acura Pharmaceuticals Inc. Stock (ACUR) is $0.8847 on average, with a high prediction of $1.233 and a low estimate of $0.5364. This represents an +88,366% increase from the previous price of $0.001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.6182 | $0.5364 | $0.70 | +61,718% |
| February, 2029 | $1.1211 | $1.1041 | $1.117 | +112.01K% |
| March, 2029 | $0.9543 | $0.9543 | $1.0782 | +95,332% |
| April, 2029 | $0.6945 | $0.6945 | $0.9114 | +69,355% |
| May, 2029 | $1.21 | $0.5657 | $1.1101 | +120.90K% |
| June, 2029 | $1.13 | $1.13 | $1.175 | +112.90K% |
| July, 2029 | $0.865 | $0.895 | $1.09 | +86,400% |
| August, 2029 | $0.685 | $0.685 | $0.82 | +68,400% |
| September, 2029 | $1.233 | $0.595 | $1.233 | +123.20K% |
| October, 2029 | $1.0877 | $1.0877 | $1.2159 | +108.67K% |
| November, 2029 | $0.8595 | $0.8595 | $1.0407 | +85,855% |
| December, 2029 | $0.7184 | $0.6243 | $0.8125 | +71,741% |
Acura Pharmaceuticals Inc. Stock (ACUR) Price Forecast for 2030
Acura Pharmaceuticals Inc. Stock (ACUR) is expected to reach an average price of $1.0592 in 2030, with a high forecast of $1.4648 and a low forecast of $0.6536. This signifies an +105.82K% surge from the last price of $0.001.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.2827 | $1.2718 | $1.2909 | +128.17K% |
| February, 2030 | $1.0914 | $1.0914 | $1.2336 | +109.04K% |
| March, 2030 | $0.85 | $0.85 | $1.0423 | +84,900% |
| April, 2030 | $1.39 | $0.6536 | $1.2901 | +138.90K% |
| May, 2030 | $1.2855 | $1.2855 | $1.3489 | +128.45K% |
| June, 2030 | $1.0859 | $1.0859 | $1.2393 | +108.49K% |
| July, 2030 | $0.7852 | $0.7852 | $0.9898 | +78,423% |
| August, 2030 | $1.4068 | $0.683 | $1.4068 | +140.58K% |
| September, 2030 | $1.2309 | $1.2309 | $1.3836 | +122.99K% |
| October, 2030 | $0.9782 | $0.9782 | $1.1777 | +97,718% |
| November, 2030 | $0.7655 | $0.7655 | $0.925 | +76,445% |
| December, 2030 | $1.4443 | $0.7123 | $1.4648 | +144.33K% |
5.71%
0.34%
Cap:
|
Volume (24h):